Cargando…

Omental Adipose Removal Decreases High Blood Pressure in Hypertensive Patients Independent of Body Mass Index

AIM: Several studies have demonstrated that increased omental adipose is a risk factor for obesity and metabolic syndrome. It remains unclear whether it is responsible for hypertension as an independent risk. This study was designed to assess the impact of omental adipose removal by surgery on blood...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Li, Sun, Wei, Zhang, Mi, Wang, Yaqing, Tian, Yunfan, Li, Peng, Lu, Yan, Xu, Tianhua, Qiu, Ming, Yang, Yun, Jia, Xuemei, Kong, Xiangqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721438/
https://www.ncbi.nlm.nih.gov/pubmed/35002265
http://dx.doi.org/10.2147/DMSO.S272879
_version_ 1784625343376654336
author Jiang, Li
Sun, Wei
Zhang, Mi
Wang, Yaqing
Tian, Yunfan
Li, Peng
Lu, Yan
Xu, Tianhua
Qiu, Ming
Yang, Yun
Jia, Xuemei
Kong, Xiangqing
author_facet Jiang, Li
Sun, Wei
Zhang, Mi
Wang, Yaqing
Tian, Yunfan
Li, Peng
Lu, Yan
Xu, Tianhua
Qiu, Ming
Yang, Yun
Jia, Xuemei
Kong, Xiangqing
author_sort Jiang, Li
collection PubMed
description AIM: Several studies have demonstrated that increased omental adipose is a risk factor for obesity and metabolic syndrome. It remains unclear whether it is responsible for hypertension as an independent risk. This study was designed to assess the impact of omental adipose removal by surgery on blood pressure in cancer patients with or without hypertension. METHODS AND RESULTS: In this prospective observational study, 133 patients with gastric or gynecological cancer were divided into 3 groups: non-hypertensive and omentum removed (NH&OR), hypertensive and omentum removed (H&OR), and hypertensive and omentum present (H&OP). Patients were followed up with systolic and diastolic blood pressure (SBP and DBP), changes in related body mass index and metabolic indices. The time points of the 2 follow-up visits were 1 month ± 7 days after the operation before the start of chemotherapy and the endpoint of 8 ± 1 month. Omental adipose tissues from both non-hypertensive and hypertensive patients in surgery were collected. We included 133 patients (84.2% female, 20.3% malignant gastric cancer and 79.7% malignant gynecological cancer, 78.2% omentum removal, 48.9% hypertensive), and all completed follow-up. H&OR group showed significant reductions in systolic and diastolic blood pressure compared with the baseline at 1-m (−16.94/-10.50 mmHg, both P < 0.001) and 8-m end point (−16.00/-5.50 mmHg, P < 0.001 and P = 0.004). Little reductions were observed with the body mass index of patients in 3 groups till the endpoint of study (H&OR group: 24.60 kg/m(2) to 23.57 kg/m(2), NH&OR group: 23.45 kg/m(2) to 23.25 kg/m(2), H&OP group: 25.74 kg/m(2) to 25.24 kg/m(2), all P > 0.05). No correlation was found between the baseline body mass index and 8-m change of systolic and diastolic blood pressure in omentum removed groups. In both groups, triglyceride levels were significantly increased at 4 ± 1 week after surgery (NH&OR 0.32 mmol/L, P = 0.006; H&OR 0.40 mmol/L, P = 0.010). CONCLUSION: Resection of omental adipose tissue represents an effective strategy for reducing systolic and diastolic blood pressure at 8 months in hypertensive patients, even in the non-obese hypertensive population.
format Online
Article
Text
id pubmed-8721438
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-87214382022-01-06 Omental Adipose Removal Decreases High Blood Pressure in Hypertensive Patients Independent of Body Mass Index Jiang, Li Sun, Wei Zhang, Mi Wang, Yaqing Tian, Yunfan Li, Peng Lu, Yan Xu, Tianhua Qiu, Ming Yang, Yun Jia, Xuemei Kong, Xiangqing Diabetes Metab Syndr Obes Original Research AIM: Several studies have demonstrated that increased omental adipose is a risk factor for obesity and metabolic syndrome. It remains unclear whether it is responsible for hypertension as an independent risk. This study was designed to assess the impact of omental adipose removal by surgery on blood pressure in cancer patients with or without hypertension. METHODS AND RESULTS: In this prospective observational study, 133 patients with gastric or gynecological cancer were divided into 3 groups: non-hypertensive and omentum removed (NH&OR), hypertensive and omentum removed (H&OR), and hypertensive and omentum present (H&OP). Patients were followed up with systolic and diastolic blood pressure (SBP and DBP), changes in related body mass index and metabolic indices. The time points of the 2 follow-up visits were 1 month ± 7 days after the operation before the start of chemotherapy and the endpoint of 8 ± 1 month. Omental adipose tissues from both non-hypertensive and hypertensive patients in surgery were collected. We included 133 patients (84.2% female, 20.3% malignant gastric cancer and 79.7% malignant gynecological cancer, 78.2% omentum removal, 48.9% hypertensive), and all completed follow-up. H&OR group showed significant reductions in systolic and diastolic blood pressure compared with the baseline at 1-m (−16.94/-10.50 mmHg, both P < 0.001) and 8-m end point (−16.00/-5.50 mmHg, P < 0.001 and P = 0.004). Little reductions were observed with the body mass index of patients in 3 groups till the endpoint of study (H&OR group: 24.60 kg/m(2) to 23.57 kg/m(2), NH&OR group: 23.45 kg/m(2) to 23.25 kg/m(2), H&OP group: 25.74 kg/m(2) to 25.24 kg/m(2), all P > 0.05). No correlation was found between the baseline body mass index and 8-m change of systolic and diastolic blood pressure in omentum removed groups. In both groups, triglyceride levels were significantly increased at 4 ± 1 week after surgery (NH&OR 0.32 mmol/L, P = 0.006; H&OR 0.40 mmol/L, P = 0.010). CONCLUSION: Resection of omental adipose tissue represents an effective strategy for reducing systolic and diastolic blood pressure at 8 months in hypertensive patients, even in the non-obese hypertensive population. Dove 2021-12-29 /pmc/articles/PMC8721438/ /pubmed/35002265 http://dx.doi.org/10.2147/DMSO.S272879 Text en © 2021 Jiang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Jiang, Li
Sun, Wei
Zhang, Mi
Wang, Yaqing
Tian, Yunfan
Li, Peng
Lu, Yan
Xu, Tianhua
Qiu, Ming
Yang, Yun
Jia, Xuemei
Kong, Xiangqing
Omental Adipose Removal Decreases High Blood Pressure in Hypertensive Patients Independent of Body Mass Index
title Omental Adipose Removal Decreases High Blood Pressure in Hypertensive Patients Independent of Body Mass Index
title_full Omental Adipose Removal Decreases High Blood Pressure in Hypertensive Patients Independent of Body Mass Index
title_fullStr Omental Adipose Removal Decreases High Blood Pressure in Hypertensive Patients Independent of Body Mass Index
title_full_unstemmed Omental Adipose Removal Decreases High Blood Pressure in Hypertensive Patients Independent of Body Mass Index
title_short Omental Adipose Removal Decreases High Blood Pressure in Hypertensive Patients Independent of Body Mass Index
title_sort omental adipose removal decreases high blood pressure in hypertensive patients independent of body mass index
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721438/
https://www.ncbi.nlm.nih.gov/pubmed/35002265
http://dx.doi.org/10.2147/DMSO.S272879
work_keys_str_mv AT jiangli omentaladiposeremovaldecreaseshighbloodpressureinhypertensivepatientsindependentofbodymassindex
AT sunwei omentaladiposeremovaldecreaseshighbloodpressureinhypertensivepatientsindependentofbodymassindex
AT zhangmi omentaladiposeremovaldecreaseshighbloodpressureinhypertensivepatientsindependentofbodymassindex
AT wangyaqing omentaladiposeremovaldecreaseshighbloodpressureinhypertensivepatientsindependentofbodymassindex
AT tianyunfan omentaladiposeremovaldecreaseshighbloodpressureinhypertensivepatientsindependentofbodymassindex
AT lipeng omentaladiposeremovaldecreaseshighbloodpressureinhypertensivepatientsindependentofbodymassindex
AT luyan omentaladiposeremovaldecreaseshighbloodpressureinhypertensivepatientsindependentofbodymassindex
AT xutianhua omentaladiposeremovaldecreaseshighbloodpressureinhypertensivepatientsindependentofbodymassindex
AT qiuming omentaladiposeremovaldecreaseshighbloodpressureinhypertensivepatientsindependentofbodymassindex
AT yangyun omentaladiposeremovaldecreaseshighbloodpressureinhypertensivepatientsindependentofbodymassindex
AT jiaxuemei omentaladiposeremovaldecreaseshighbloodpressureinhypertensivepatientsindependentofbodymassindex
AT kongxiangqing omentaladiposeremovaldecreaseshighbloodpressureinhypertensivepatientsindependentofbodymassindex